☆ 4.3 Editorial Material

Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation

LEUKEMIA RESEARCH (2011)

Journal

LEUKEMIA RESEARCH

Volume 35, Issue 3, Pages 422-423

Publisher

PERGAMON-ELSEVIER SCIENCE LTD

DOI: 10.1016/j.leukres.2010.10.025

Keywords

-

Categories

Oncology Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.